In vitro experiments showed that EFNB2 promoted the viability of CRC cells via EPHB4, but not the other EPH receptors (EPHB1, EPHB2, EPHB3, EPHB6, and EPHA4) (Figs. 3B and S3A–S3F). Here, EPHB2 is linked to colorectal carcinoma.